The long term protection of screening & vaccination programs
Monday, October 9, 2017
•
MSS 02
•
9:30 AM
>
11:00 AM
•
The long term protection of screening & vaccination programs
•
Auditorium
•
MSS 02-01
•
Cytology contribution
See abstract
>
G.
Guglielmo
RONCO
•
MSS 02-02
•
HPV screening including cotesting
>
J.
Joakim
DILLNER
•
MSS 02-03
•
HPV triage
See abstract
>
J.
Johannes
Berkhof
•
MSS 02-04
•
Protection of 4&2 valent HPV vaccine
>
J.
Jorma
PAAVONEN
•
MSS 02-05
•
Expected impact of 9-valent HPV vaccine
See abstract
>
M.
Mark
JIT
•
MSS 02-06
•
Residual life time risk of cervical cancer following screening and vaccination
See abstract
>
P.
Paolo
Giorgi Rossi
|